9.78

2.19% +0.21

After Hours: 9.78

Enfusion Inc (ENFN)

Overview News Price History Option Chain Discussions Forecast

Enfusion Inc stock is currently priced at $9.78, with a 24-hour trading volume of 385.33K. It has seen a +2.19% increased in the last 24 hours and a +4.04% rose in the past month. The chart indicates a potential bullish trend, as the stock is above the $9.57 pivot point. If it approaches the $9.88 resistance level, significant changes may occur.

Previous Close:

$9.57

Open:

$9.61

24h Volume:

385.33K

Market Cap:

$888.78M

Revenue:

$174.54M

Net Income/Loss:

$6.03M

P/E Ratio:

122.25

EPS:

0.08

Net Cash Flow:

$15.96M

1W Performance:

+2.95%

1M Performance:

+4.04%

6M Performance:

+18.12%

1Y Performance:

+13.06%

1D Range:

$9.60

$9.84

52W Range:

$7.37

$11.56

Enfusion Inc Stock (ENFN) Company Profile

Name

Enfusion Inc

Sector

Technology (787)

Industry

Software - Application (272)

Phone

312 253 9800

Address

125 South Clark Street, Suite 750, Chicago

Employee

639

Twitter

Next Earnings Date

2024-05-09

Latest SEC Filings

ENFN's Discussions on Twitter

Enfusion Inc Stock (ENFN) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Apr-03-23	Initiated	Piper Sandler	Neutral
Mar-15-23	Initiated	JP Morgan	Neutral
Jan-04-23	Downgrade	BofA Securities	Neutral → Underperform
Jan-03-23	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Oct-03-22	Downgrade	BofA Securities	Buy → Neutral
Nov-15-21	Initiated	BofA Securities	Buy
Nov-15-21	Initiated	Credit Suisse	Neutral
Nov-15-21	Initiated	Goldman	Neutral
Nov-15-21	Initiated	Morgan Stanley	Equal-Weight
Nov-15-21	Initiated	Piper Sandler	Overweight
Nov-15-21	Initiated	Stifel	Buy
Nov-15-21	Initiated	William Blair	Outperform

View All

Enfusion Inc Stock (ENFN) Latest News

A Glimpse Into The Expert Outlook On Enfusion Through 4 Analysts

Benzinga

Enfusion, Inc. (ENFN) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates

Zacks Investment Research

Enfusion Stock To Remain Range-Bound In 2024 Amid Stable Hedge Fund Market: Goldman Sachs Analyst Downgrades Stock

Benzinga

Enfusion Inc Stock (ENFN) Financials Data

Enfusion Inc (ENFN) Revenue 2024

ENFN reported a revenue (TTM) of $174.53 million for the quarter ending December 31, 2023, a +16.09% rise year-over-year.

Enfusion Inc (ENFN) Net Income 2024

ENFN net income (TTM) was $6.03 million for the quarter ending December 31, 2023, a +178.72% increase year-over-year.

Enfusion Inc (ENFN) Cash Flow 2024

ENFN recorded a free cash flow (TTM) of $15.96 million for the quarter ending December 31, 2023, a +156.43% increase year-over-year.

Enfusion Inc (ENFN) Earnings per Share 2024

ENFN earnings per share (TTM) was $0.08 for the quarter ending December 31, 2023, a +180.00% growth year-over-year.

Enfusion Inc Stock (ENFN) Insider Trading

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total
Campobasso Matthew	General Counsel	Feb 29 '24	Sale	8.73	108	943	30,840
Gutowski Valeria	Chief Accounting Officer	Feb 29 '24	Sale	8.73	27	236	17,570
Somers Deirdre	Director	Jan 10 '24	Sale	8.65	1,770	15,310	34,471
Herring Bradley	Chief Financial Officer	Jan 09 '24	Sale	8.95	2,090	18,706	211,600
Movchan Oleg	Chief Executive Officer	Jan 09 '24	Sale	8.95	1,355	12,127	269,954
Campobasso Matthew	General Counsel	Jan 09 '24	Sale	8.95	493	4,412	30,948
Bastone Bronwen	Chief People Officer	Jan 09 '24	Sale	8.95	410	3,669	153,846
Herring Bradley	Chief Financial Officer	Jan 08 '24	Sale	9.23	1,998	18,442	213,690
Movchan Oleg	Chief Executive Officer	Jan 08 '24	Sale	9.23	1,295	11,953	271,309
Campobasso Matthew	General Counsel	Jan 08 '24	Sale	9.23	472	4,357	31,441

Enfusion Inc. offers software-as-a-service for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It provides portfolio management system, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and order and execution management system that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines. The company also offers accounting/general ledger system, a real-time accounting book of record for chief financial officers, chief operating officers, accountants, and operations teams; Enfusion analytics system, which enables CIOs, portfolio managers, traders, and analysts to analyze portfolios through time horizons and automate customized visualized reports for internal and external stakeholders; and technology-powered services. Enfusion Inc. was incorporated in 2021 and is headquartered in Chicago, Illinois.